BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26591164)

  • 21. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
    Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS
    Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R; Ziporen L; Mader R; Neumann L; Buskila D
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
    Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study.
    Abid N; Khan AS; Al Otaibi FH
    Lupus; 2013 Dec; 22(14):1529-33. PubMed ID: 23934402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations.
    Anuardo P; Verdier M; Gormezano NW; Ferreira GR; Leal GN; Lianza A; Ferreira JC; Pereira RM; Aikawa NE; Terreri MT; Magalhães CS; Appenzeller S; Dos Santos MC; Sachetti SB; Len CA; Pilleggi GS; Lotufo S; Bonfá E; Silva CA
    Pediatr Cardiol; 2017 Feb; 38(2):234-239. PubMed ID: 27826712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
    Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
    Dayama A; Dass J; Mahapatra M; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus.
    Kamboh MI; Manzi S; Mehdi H; Fitzgerald S; Sanghera DK; Kuller LH; Atson CE
    Lupus; 1999; 8(9):742-50. PubMed ID: 10602447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
    Lundström E; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Källberg H; Sandling JK; Syvänen AC; Klareskog L; Gunnarsson I; Rönnblom L; Padyukov L; Svenungsson E
    Ann Rheum Dis; 2013 Jun; 72(6):1018-25. PubMed ID: 22893315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.